PHRM 720 Exam 1 questions + inclass questions

0.0(0)
Studied by 0 people
call kaiCall Kai
Locked
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/81

encourage image

There's no tags or description

Looks like no tags are added yet.

Last updated 6:35 PM on 8/24/26
Name
Mastery
Learn
Test
Matching
Spaced
Call with Kai
Chat

No analytics yet

Send a link to your students to track their progress

82 Terms

1
New cards

Chlorothiazide Class

A drug belonging to the thiazide diuretic class of antihypertensive medications.

2
New cards

Lisinopril Class

A drug belonging to the ACE (angiotensin-converting enzyme) inhibitor class.

3
New cards

Valsartan Class

A drug belonging to the ARB (angiotensin receptor blocker) class.

4
New cards

Spironolactone Class

A drug belonging to the mineralocorticoid receptor blocker class.

5
New cards

Losartan Imidazole Ring Features

An essential SAR element of losartan containing a 22-alkylated chain (343\text{--}4 atoms long), a 44-substitution, and a 33-phenylmethyl substitution.

6
New cards

Peptide Mimetic Concept

A medicinal chemistry strategy designed to mimic amino acid side chains while eliminating hydrolyzable peptide/amide bonds.

7
New cards

Mechanisms Increasing Cardiac Output

Physiological mechanisms that increase blood pressure by elevating cardiac output, including SNS activation, renal Na+\text{Na}^+ and H2O\text{H}_2\text{O} reabsorption, and increased blood volume.

8
New cards

Chronic Response to SNS Inhibition

A compensatory increase in Na+\text{Na}^+ and H2O\text{H}_2\text{O} reabsorption from urine by the kidneys following administration of an efficacious SNS inhibitor like an alpha-2 agonist.

9
New cards

Microzide

The brand name for hydrochlorothiazide (HCTZ), a thiazide diuretic used to treat hypertension.

10
New cards

Mechanism of Action of Microzide

Inhibits the Na+/Cl\text{Na}^+/\text{Cl}^- transporter in the distal tubule, inducing diuresis and natriuresis, and ultimately reducing PVR.

11
New cards

Microzide-Induced Hypokalemia Management

Strategies including potassium supplementation, or co-prescribing spironolactone, triamterene, a Na+\text{Na}^+ ion channel blocker, or a mineralocorticoid receptor antagonist.

12
New cards

Triamterene Pharmacological Mechanism

Prevents diuretic-induced hypokalemia by blocking sodium ion channels in the distal nephron.

13
New cards

Cozaar Mechanism for PVR Reduction

Reduces peripheral vascular resistance as a competitive antagonist of the AT1\text{AT}_1 receptor, decreasing arteriolar vasoconstriction and aldosterone secretion.

14
New cards

Trough-to-Peak Ratio > 50%

A pharmacokinetic benchmark indicating that uniform reduction in blood pressure over 24 hours24\text{ hours} can be achieved with once-daily dosing.

15
New cards

Altace

The brand name for ramipril, an ACE inhibitor used in hypertension management.

16
New cards

Altace Mechanism of Increasing Serum Creatinine

Acts on the efferent glomerular arteriole to reduce intraglomerular pressure, resulting in a decreased GFR.

17
New cards

Altace Mechanism of Hyperkalemia

Decreases aldosterone synthesis in the adrenal cortex, leading to reduced renal potassium excretion.

18
New cards

Indication to Switch Altace to Labetalol

Patient pregnancy, during which ACE inhibitors like Altace are contraindicated.

19
New cards

Procardia

The brand name for nifedipine, a calcium channel blocker.

20
New cards

Procardia Mechanism of Action

Selectively blocks voltage-gated Ca2+\text{Ca}^{2+} channels in resistance arterioles to lower PVR.

21
New cards

Norvasc Side Effect

A brand name for amlodipine, a calcium channel blocker commonly associated with peripheral edema.

22
New cards

ACE Inhibitor Transition-State Design

Designing inhibitor molecules to mimic the tetrahedral transition state of peptide cleavage, allowing tight and stable binding to the active site.

23
New cards

Zinc (Zn²⁺) Coordination in ACE

An essential active-site interaction where transition-state mimics coordinate with the catalytic Zn2+\text{Zn}^{2+} ion to block catalytic turnover.

24
New cards

Orally Active AT1 Antagonist Design Strategy

Replacing peptide bonds with nonpeptide structural features that mimic important angiotensin II side chains while resisting GI hydrolysis.

25
New cards

Chlorthalidone Half-Life

Approximately 47 hours47\text{ hours}.

26
New cards

Hydrochlorothiazide Half-Life

Between 22 and 3 hours3\text{ hours}.

27
New cards

Indapamide Half-Life

Approximately 14 hours14\text{ hours}.

28
New cards

Chlorthalidone vs HCTZ Potency

Chlorthalidone is more potent on a mg-to-mg basis and produces greater reductions in office blood pressure than hydrochlorothiazide.

29
New cards

Chlorthalidone CV Outcomes in Stroke/MI

Demonstrates a statistically significant lower risk of cardiovascular events (p=0.02p = 0.02) compared to HCTZ in patients with a history of stroke or MI.

30
New cards

HCTZ Combination Products

Over 2525 commercially available single-tablet antihypertensive combination products incorporate HCTZ.

31
New cards

Chlorthalidone Combination Products

Only 22 commercially available single-tablet combination products contain chlorthalidone (Atenolol + chlorthalidone; Azilsartan + chlorthalidone).

32
New cards

Indapamide Combination Products

Only 11 commercially available single-tablet combination product contains indapamide (Telmisartan + amlodipine + indapamide).

33
New cards

Compensatory Response to Reduced Stroke Volume

An increase in heart rate to help maintain cardiac output and blood pressure.

34
New cards

Adherence Strategy for Home BP Monitoring

Initiating daily home blood pressure monitoring to improve medication adherence in patients unmotivated by simple refill reminders.

35
New cards

Furosemide + Metoprolol Synergy

A drug combination providing synergistic BP reduction by targeting different components of the blood pressure equation.

36
New cards

Olmesartan Ang II Side Chain Mimicry

Designed to mimic specific side-chain interactions of Angiotensin II, such as Asp-1, Tyr-4, Ile-5, His-6, or Phe-8.

37
New cards

Efferent Glomerular Arteriole

The primary site of vascular action where ACE inhibitors reduce intraglomerular pressure and GFR.

38
New cards

Distal Tubule Na+/Cl- Transporter

The specific renal transport system targeted and inhibited by Microzide.

39
New cards

2-Alkyl Group of Losartan

A side chain approximately 343\text{--}4 atoms long attached to the 22-position of the imidazole ring required for ARB activity.

40
New cards

4-Substituted Imidazole Group

A structural feature in ARBs that can form part of a further cyclic ring structure.

41
New cards

Terminal Tetrazole or Carboxyl Group

An acidic group located on the 44-position of the phenylmethyl ring in ARBs that mimics acidic amino acid features.

42
New cards

Cardizem

The brand name for diltiazem, a non-dihydropyridine calcium channel blocker.

43
New cards

Enalapril

An ACE inhibitor drug used as an antihypertensive agent.

44
New cards

Atenolol + Chlorthalidone

One of the two commercially available single-tablet combination formulations containing chlorthalidone.

45
New cards

Azilsartan + Chlorthalidone

One of the two commercially available single-tablet combination formulations containing chlorthalidone.

46
New cards

Telmisartan + Amlodipine + Indapamide

The single commercially available single-tablet combination product containing indapamide.

47
New cards

Hyperkalemia Mechanism of ACE Inhibitors

Decreased aldosterone synthesis resulting in reduced renal potassium excretion.

48
New cards

Peripheral Edema in CCB Therapy

An adverse effect commonly caused by dihydropyridine calcium channel blockers such as Norvasc (amlodipine).

49
New cards

Management of HTN with Microalbuminuria

Continuing high-dose ACE inhibitor therapy (e.g., Lisinopril 40 mg40\text{ mg}) when blood pressure goals (130/80 mmHg130/80\text{ mmHg}) are met and microalbuminuria is present.

50
New cards

Stage 1 HTN Management with CVD Risk > 10%

Initiation of antihypertensive monotherapy (e.g., Chlorthalidone) in patients with BP 136/88 mmHg136/88\text{ mmHg} and a 10-year CVD risk of 12.1\text{ %}.

51
New cards

Aldosterone increases BP by which of the following mechanisms? Select the single best answer. (1 pt)


A: Increases constriction of precapillary arterioles which increases PVR

B: Increases SNS outflow from the brainstem which increases C O

C: Increases Ang II expression which increases PVR

D: Increases Na+ and water re absorption from the urine filtrate which increases PVR

E: Increases Na+ and water re absorption from the urine which increases CO

E: Increases Na+ and water re absorption from the urine which increases CO

52
New cards

What is/are the mechanisms by which the SNS increases BP? (select all that apply, no partial credit given; 2 pts)


A: NE stimulates alpha-2 receptors and increases aldosterone which increases CO

B: NE stimulates beta-1 receptors and increases CO

C: NE stimulates alpha-1 receptors and increases PVR

D: NE stimulates beta-2 receptors and increases PVR

E: NE stimulates alpha-2 receptors and increases PVR

B: NE stimulates beta-1 receptors and increases C O

C: NE stimulates alpha-1 receptors and increases PVR

53
New cards

Which of the following would (either directly or indirectly) increase cardiac output? (select all that apply, no partial credit given; 2 pts)


A: Reduction in heart rate

B: Vasoconstriction

C: Increase in blood volume

D: Vasodilation

C: Increase in blood volume

D: Vasodilation

54
New cards

State 2 proven strategies that have not yet been tried may help this patient be more adherent to her antihypertensive regimen.

1. Get an At-Home Blood Pressure Monitor. 2. Switch to Lisinopril/HCTZ, which is an ACEi and thiazide diuretic and can betaken as one pill instead of 2.

55
New cards

While you may or may not agree, the decision was made to begin single-drug antihypertensive drug therapy for this patient. In this situation, which ONE drug would you recommend? (2 pts)


I would put her on a C a2+ Channel blocker such as Amlodipine.

56
New cards

Aldosterone increases BP by which of the following mechanisms? Select the single best answer. (1 pt)


A: Incre ases constriction of precapillary arterioles which incre ases PVR

B: Incre ases SNS outflow from the brainstem which incre ases C O

C: Increases Ang II expression which incre ases PVR

D: Increases Na+ and water re absorption from the urine filtrate which incre ases PVR

E: Increases Na+ and water re absorption from the urine which incre ases C O

E: Increases Na+ and water re absorption from the urine which increases C O

57
New cards

What is/are the mechanisms by which the SNS increases BP? (select all that apply, no partial credit given; 2 pts)

Original Order: 4

A: NE stimulates alpha-2 receptors and incre ases aldosterone which incre ases C O

B: NE stimulates beta-1 receptors and incre ases C O

C: NE stimulates alpha-1 receptors and incre ases PVR

D: NE stimulates beta-2 receptors and incre ases PVR

E: NE stimulates alpha-2 receptors and incre ases PVR

B: NE stimulates beta-1 receptors and incre ases C O

C: NE stimulates alpha-1 receptors and incre ases PVR

58
New cards

Which one of the following drugs would - in theory - hold the most potential as an antihypertensive medication?

(2 pts)

Original Order: 5

A: A drug which blocks endothelin degradation

B: A drug which blocks angiotensin II degradation

C: A drug which stimulates nitric oxide rele ase

D: A drug which stimulates rele ase of aldosterone

C: A drug which stimulates nitric oxide rele ase

59
New cards

Which of the following would (either directly or indirectly) increase cardiac output? (select all that apply, no

partial credit given; 2 pts)

Original Order: 6

A: Reduction in he art rate

B: Vasoconstriction

C: Incre ase in blood volume

D. Vasodilation

C: Incre ase in blood volume

D. Vasodilation

60
New cards

What is the mechanism of action by which Cozaar causes hyperkalemia as a side effect? Select the one best

answer. (1 pt)

Original Order: 9

A: Decre ases aldosterone synthesis

B: Incre ases glomerular filtration rate

C: Decre ases intraglomerular pressure

D: Decre ases blood volume

E: Incre ases dilation at afferent arteriole

A: Decre ases aldosterone synthesis

61
New cards

What is the mechanism of action of nifedipine for treating hypertension? (select all that apply, no partial credit

given; 1 pt)

Original Order: 11

A: Site of action is selective to cardiac SA and AV nodes, and cardiomyocytes

B: Site of action is selective to the resistance arteriole

C: Reduces C O and PVR

D: Blocks voltage-gated Ca2+ channels

E: Reduces C O

B: Site of action is selective to the resistance arteriole

D: Blocks voltage-gated Ca2+ channels

62
New cards

A patient has uncomplicated hypertension and is being treated with Lotensin and Procardia. The patient has

developed swelling in the ankles and feet. Which drug (A or B) is causing this effect and why (C, D, or E)? (select

all that apply, no partial credit given; 2 pts)

Original Order: 12

A: Lotensin

B: Procardia

C: Results from arteriolar dilation and incre ased in capillary pressure

D: Results from non-allergic re action due to incre ases in bradykinin

E: Results from incre ases in blood volume and fluid extravasation from capillaries

B: Procardia

C: Results from arteriolar dilation and incre ased in capillary pressure

63
New cards

Which of the following is part of the mechanism of action of Prinivil that causes dry cough? Select one best

answer. (1 pt)

Original Order: 13

A: It competitively inhibits angiotensinogen binding to renin, decre asing Ang I and Ang II synthesis

B: It decre ases Ang II synthesis and aldosterone secretion

C: It inhibits the degradation of bradykinin

D: It is an antagonist at the AT1 receptors, reducing aldosterone synthesis

E: It is a beta-2 antagonist

C: It inhibits the degradation of bradykinin

64
New cards

What is the mechanism of action by which Thalitone causes the side effect of hypokalemia? (select all that apply,

no partial credit given; 2 pts)

Original Order: 15

A: Inhibits the Na+/Cl- transporter in the distal tubule

B: Inhibits the Na+/K+ ATPase in the distal tubule

C: Delivers more Cl- to the collecting duct

D: Incre ases K+ re absorption from the urine filtrate in the collecting duct

E: Delivers more Na+ to the collecting duct

A: Inhibits the Na+/Cl- transporter in the distal tubule

E: Delivers more Na+ to the collecting duct

65
New cards

What is the pharmacological mechanism of triamterene for preventing hypokalemia? (1 pt)

Original Order: 16

A: Mineralocorticoid receptor antagonist

B: Blocks the Na+ ion channel

C: AT1 receptor antagonist

D: Blocks the K+ ion channel

E: Inhibits Na+/K+ ATPase

B: Blocks the Na+ ion channel

66
New cards

What is the mechanism of action of propranolol for treating hypertension? (select all that apply, no partial credit

given; 1 pt)

Original Order: 18

A: Site of action is resistance arterioles

B: Competitive antagonist of beta-2 receptor

C: C auses vasodilation and reduces PVR

D: Site of action is SA node and cardiac myocytes

E: Reduces HR and C O

F: Competitive antagonist of beta-1 receptor

B: Competitive antagonist of beta-2 receptor

D: Site of action is SA node and cardiac myocytes

E: Reduces HR and C O

F: Competitive antagonist of beta-1 receptor

67
New cards

Which of the following is a possible side effect of terazosin? (1 pt)

Original Order: 20

A: Dry cough

B: Angioedema

C: Postural hypotension

D: Sle ep disturbances

E: Depression

C: Postural hypotension

68
New cards
<p>Which one of the following medications is most appropriate to administer to this patient at this time? (2 pts)</p><p>Original Order: 25</p><p>A: Oral labetalol</p><p>B: Oral chlorthalidone</p><p>C: Intravenous carvedilol</p><p>D: Intravenous clevidipine</p>

Which one of the following medications is most appropriate to administer to this patient at this time? (2 pts)

Original Order: 25

A: Oral labetalol

B: Oral chlorthalidone

C: Intravenous carvedilol

D: Intravenous clevidipine

D: Intravenous clevidipine

69
New cards
<p>State 2 proven strategies that have not yet been tried may help this patient be more adherent to her</p><p>antihypertensive regimen. (2 pts)</p><p>Original Order: 26</p><p></p>

State 2 proven strategies that have not yet been tried may help this patient be more adherent to her

antihypertensive regimen. (2 pts)

Original Order: 26


A: - Have the patient obtain a blood pressure kit monitor to track her blood pressure regularly. - Give the patient combination drugs

or long acting medication for qd inste ad of bid.

70
New cards
<p>While you may or may not agree, the decision was made to begin single-drug antihypertensive drug therapy for</p><p>this patient. In this situation, which ONE drug would you recommend? (2 pts)</p><p>Original Order: 28</p><p>A: Amlodipine</p><p>B: Chlorthalidone</p><p>C: Diltia z em</p><p>D: Lisinopril</p>

While you may or may not agree, the decision was made to begin single-drug antihypertensive drug therapy for

this patient. In this situation, which ONE drug would you recommend? (2 pts)

Original Order: 28

A: Amlodipine

B: Chlorthalidone

C: Diltia z em

D: Lisinopril

D: Lisinopril

71
New cards
<p>Based on the structures below, which of the following is mineralocorticoid receptor antagonist that can cause hormonal side effects?</p><p>A. A</p><p>B. B</p><p>C. C</p><p>D. D</p><p>E. Impossible to tell</p>

Based on the structures below, which of the following is mineralocorticoid receptor antagonist that can cause hormonal side effects?

A. A

B. B

C. C

D. D

E. Impossible to tell

B. B

72
New cards
<p>based on the structure-activity relationship of beta-blockers, which is expected to be cardioselective</p><p>A. A      Carvedilol</p><p>B. B      Pindolol</p><p>C. C      Timolol</p><p>D. D      Atenolol</p><p>E. E       Nadolol</p>

based on the structure-activity relationship of beta-blockers, which is expected to be cardioselective

A. A Carvedilol

B. B Pindolol

C. C Timolol

D. D Atenolol

E. E Nadolol

D. it is atenolol

73
New cards
<p>While you may or may not agree, the decision was made to begin single-drug antihypertensive drug therapy for</p><p>this patient. In this situation, which ONE drug would you recommend? (2 pts)</p>

While you may or may not agree, the decision was made to begin single-drug antihypertensive drug therapy for

this patient. In this situation, which ONE drug would you recommend? (2 pts)

You can start the patient on a CCB or a thiazide siuretic

74
New cards
term image

C. Increase Candesartan dosage

75
New cards
term image

D. weight reduction

76
New cards
term image

B. Felodipine

77
New cards
term image
  • Stop Norvasc (amlodipine) 2.5 mg daily: This eliminates the offending agent driving the peripheral edema.

  • Reduce Microzide (hydrochlorothiazide) to 12.5 mg or 25 mg daily: This lowers the metabolic and electrolyte risks of high-dose thiazide therapy while retaining essential first-line blood pressure coverage.


78
New cards
term image

Add metoprolol and maybe a ACE inhibitor for further blood pressure control, such as lisinopril, checking serum creatinine and potassium

79
New cards
term image

Frequent lab monitoring for potassium and creatinine level. watch for any swelling of the face, discontinue lisinopril immediately and seek medical attention ASAP. monitor bp at home.

80
New cards

What is the highest recommended daily intake of sodium for a patient with hypertension according to the

American Heart Association? (1 pt)

A: 1300 mg

B: 1500 mg

C: 2000 mg

D: 2300 mg

D: 2300 mg

81
New cards
82
New cards

A 62-year-old White male is being seen in the Emergency Department with a chief complaint of fatigue and lack of

energy. Laboratory results show a potassium of 3.9 mEq/L (normal 3.8-5.0 mEq/L) and serum creatinine of 0.8

mg/dL (normal 0.5-1.3 mg/dL). Physical examination is remarkable for right knee tenderness. Two blood pressure

readings are taken which are 204/118 mmHg and 212/108 mmHg with corresponding heart rates of 84 and 88 bpm.

Which one of the following medications is most appropriate to administer to this patient at this time? (2 pts)

A: Oral labetalol

B: Sublingual nitroglycerin

C: Intravenous carvedilol

D: Intravenous clevidipine

A: Oral labetolol